Skip header and navigation

1 records – page 1 of 1.

25-Hydroxycholecaliferol and fractures of the proximal.

https://arctichealth.org/en/permalink/ahliterature252013
Source
Lancet. 1975 Aug 16;2(7929):300-2
Publication Type
Article
Date
Aug-16-1975
Author
B. Lund
O H Sorensen
A B Christensen
Source
Lancet. 1975 Aug 16;2(7929):300-2
Date
Aug-16-1975
Language
English
Publication Type
Article
Keywords
Adult
Age Factors
Aged
Alkaline Phosphatase - blood
Calcium - blood
Clinical Trials as Topic
Denmark
Femoral Fractures - blood - epidemiology - etiology
Great Britain
Humans
Hydroxycholecalciferols - blood - metabolism
Kidney - metabolism
Middle Aged
Osteomalacia - blood - complications - etiology
Phosphorus - blood
Seasons
Vitamin D - administration & dosage
Abstract
Plasma 25-hydroxycholecalciferol (25-H.C.C.) has been measured in 67 consective cases of fracture of the proximal femur. The values found in these patients were not different from values found in these patients were not different from those in control groups at the same time of the year. Plasma 25-H.C.C. was not correlated to plasma calcium or phosphorus, the Ca times P product, or the alkaline phosphatase. X-rays showed Looser zones in only 1 patient, in whom the lowest plasma 25-H.C.C. was found. Osteomalacia is not uncommon among elderly people in Denmark, but it is more likely to depend on a decline in the renal efficiency to convert 25-H.C.C. to 1,25-dihydroxycholecalciferol than a low dietary intake of vitamin D.
PubMed ID
50509 View in PubMed
Less detail